FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Colin Feyerabend

Research Profile

Chemicals & Drugs

Activities & Behaviors

Disorders

Phenomena

Tobacco Smoke Pollution

Procedures

Anatomy

Saliva

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Martin J Jarvis; Jennifer Mindell; Anna B Gilmore; Colin Feyerabend; Robert West
Smoke-free homes in England: prevalence, trends and validation by cotinine in children.
Martin J Jarvis; Jennifer Fidler; Jennifer Mindell; Colin Feyerabend; Robert West
Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited.
John R Ingram; Philip A Routledge; John Rhodes; RW Marshall; DC Buss; Brian K Evans; Colin Feyerabend; G A O Thomas
Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Colin Feyerabend (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Martin J Jarvis; Jennifer Mindell; Anna B Gilmore; Colin Feyerabend; Robert West
Smoke-free homes in England: prevalence, trends and validation by cotinine in children.
Tobacco control 2009;18(6):491-5.
2008: Martin J Jarvis; Jennifer Fidler; Jennifer Mindell; Colin Feyerabend; Robert West
Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited.
Addiction (Abingdon, England) 2008;103(9):1553-61.
2004: John R Ingram; Philip A Routledge; John Rhodes; RW Marshall; DC Buss; Brian K Evans; Colin Feyerabend; G A O Thomas
Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.
Alimentary pharmacology & therapeutics 2004;20(8):859-65.
2004: Peter H Whincup; Julie A Gilg; Jonathan R Emberson; Martin J Jarvis; Colin Feyerabend; Andrew Bryant; Mary Walker; Derek G Cook
Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement.
BMJ (Clinical research ed.) 2004;329(7459):200-5.
2003: Martin J Jarvis; Paola Primatesta; Bob Erens; Colin Feyerabend; Andrew Bryant
Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2003;5(3):349-55.
2001: Martin J Jarvis; Colin Feyerabend; Andrew Bryant; B Hedges; Paola Primatesta
Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners.
Tobacco control 2001;10(4):368-74.
2001: Martin J Jarvis; R Boreham; Paola Primatesta; Colin Feyerabend; Andrew Bryant
Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey.
Journal of the National Cancer Institute 2001;93(2):134-8.
2000: Martin J Jarvis; E Goddard; V Higgins; Colin Feyerabend; Andrew Bryant; Derek G Cook
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys.
BMJ (Clinical research ed.) 2000;321(7257):343-5.
1999: John T Green; Brian K Evans; John Rhodes; G A O Thomas; C Ranshaw; Colin Feyerabend; MA Russell
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
British journal of clinical pharmacology 1999;48(4):485-93.
1998: John A Stapleton; MA Russell; Gay Sutherland; Colin Feyerabend
Nicotine availability from Eclipse tobacco-heating cigarette.
Psychopharmacology 1998;139(3):288-90.
1998: Jonathan Foulds; MA Russell; Martin J Jarvis; Colin Feyerabend
Nicotine absorption and dependence in unlicensed lozenges available over the counter.
Addiction (Abingdon, England) 1998;93(9):1427-31.
1998: John T Green; John Rhodes; Krish Ragunath; G A O Thomas; Geraint T Williams; V Mani; Colin Feyerabend; MA Russell
Clinical status of ulcerative colitis in patients who smoke.
The American journal of gastroenterology 1998;93(9):1463-7.
1998: AP van Dijk; M A C Meijssen; A J Brouwer; Wim C J Hop; JD van Bergeijk; Colin Feyerabend; J H Paul Wilson; Freek J Zijlstra
Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers.
European journal of clinical investigation 1998;28(8):664-71.
1998: John T Green; John Rhodes; G A O Thomas; Brian K Evans; Colin Feyerabend; MA Russell; WJ Sandborn
Nicotine carbomer enemas--pharmacokinetics of a revised formulation.
Italian journal of gastroenterology and hepatology 1998;30(3):260-5.
1997: John T Green; G A O Thomas; John Rhodes; Geraint T Williams; Brian K Evans; MA Russell; Colin Feyerabend; P Rhodes; WJ Sandborn
Nicotine enemas for active ulcerative colitis--a pilot study.
Alimentary pharmacology & therapeutics 1997;11(5):859-63.
1997: John T Green; G A O Thomas; John Rhodes; Brian K Evans; MA Russell; Colin Feyerabend; G S Fuller; Robert G Newcombe; WJ Sandborn
Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis.
Clinical pharmacology and therapeutics 1997;61(3):340-8.
1997: G A O Thomas; R D Pullan; Freek J Zijlstra; B J Rankin; MA Russell; Colin Feyerabend; A Allen; John Rhodes
Effect of nicotine on large bowel mucus thickness, eicosanoids and faecal proteinase in ferrets.
European journal of gastroenterology & hepatology 1997;9(2):179-82.
1996: S Madretsma; L M Wolters; JP van Dijk; C J Tak; Colin Feyerabend; J H Paul Wilson; Freek J Zijlstra
In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells.
European journal of gastroenterology & hepatology 1996;8(10):1017-20.
1996: G A O Thomas; John Rhodes; K Ragunath; V Mani; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend
Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
European journal of gastroenterology & hepatology 1996;8(8):769-76.
1995: G Sutherland; John A Stapleton; MA Russell; Colin Feyerabend
Naltrexone, smoking behaviour and cigarette withdrawal.
Psychopharmacology 1995;120(4):418-25.
1995: G A O Thomas; John Rhodes; V Mani; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend
Transdermal nicotine as maintenance therapy for ulcerative colitis.
The New England journal of medicine 1995;332(15):988-92.
1995: John A Stapleton; MA Russell; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; D Wiseman
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.
Addiction (Abingdon, England) 1995;90(1):31-42.
1994: Jonathan Foulds; K McSorley; J Sneddon; Colin Feyerabend; M J Jarvis; MA Russell
Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study.
Psychopharmacology 1994;115(1-2):163-6.
1994: R D Pullan; John Rhodes; S Ganesh; V Mani; J S Morris; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend; G A O Thomas
Transdermal nicotine for active ulcerative colitis.
The New England journal of medicine 1994;330(12):811-5.
1994: Freek J Zijlstra; E D Srivastava; M Rhodes; A P van Dijk; F Fogg; H J Samson; M Copeman; MA Russell; Colin Feyerabend; Geraint T Williams
Effect of nicotine on rectal mucus and mucosal eicosanoids.
Gut 1994;35(2):247-51.
1993: MA Russell; John A Stapleton; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; P Connor
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
BMJ (Clinical research ed.) 1993;306(6888):1308-12.
1993: G Sutherland; MA Russell; John A Stapleton; Colin Feyerabend
Glycerol particle cigarettes: a less harmful option for chronic smokers.
Thorax 1993;48(4):385-7.
1993: Jonathan Foulds; J Stapleton; M Hayward; MA Russell; Colin Feyerabend; T Fleming; J Costello
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Archives of family medicine 1993;2(4):417-23.
1992: G Sutherland; John A Stapleton; MA Russell; M J Jarvis; P Hajek; M Belcher; Colin Feyerabend
Randomised controlled trial of nasal nicotine spray in smoking cessation.
Lancet 1992;340(8815):324-9.
1992: Jonathan Foulds; J Stapleton; Colin Feyerabend; C Vesey; M Jarvis; MA Russell
Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study.
Psychopharmacology 1992;106(3):421-7.
1992: M J Jarvis; Jonathan Foulds; Colin Feyerabend
Exposure to passive smoking among bar staff.
British journal of addiction 1992;87(1):111-3.
1992: G Sutherland; MA Russell; J Stapleton; Colin Feyerabend; O Ferno
Nasal nicotine spray: a rapid nicotine delivery system.
Psychopharmacology 1992;108(4):512-8.
1991: E D Srivastava; MA Russell; Colin Feyerabend; J G Masterson; John Rhodes
Sensitivity and tolerance to nicotine in smokers and nonsmokers.
Psychopharmacology 1991;105(1):63-8.
1990: E D Srivastava; MA Russell; Colin Feyerabend; John Rhodes
Effect of ulcerative colitis and smoking on rectal blood flow.
Gut 1990;31(9):1021-4.
1990: MA Russell; M J Jarvis; G Jones; Colin Feyerabend
Non-smokers show acute tolerance to subcutaneous nicotine.
Psychopharmacology 1990;102(1):56-8.
1989: P Hajek; M J Jarvis; M Belcher; G Sutherland; Colin Feyerabend
Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study.
Psychopharmacology 1989;97(1):99-102.
1988: P Hajek; M Belcher; Colin Feyerabend
Preference for 2 mg versus 4 mg nicotine chewing gum.
British journal of addiction 1988;83(9):1089-93.
1988: M J Jarvis; MA Russell; N L Benowitz; Colin Feyerabend
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.
American journal of public health 1988;78(6):696-8.
1987: M J Jarvis; H Tunstall-Pedoe; Colin Feyerabend; C Vesey; Y Saloojee
Comparison of tests used to distinguish smokers from nonsmokers.
American journal of public health 1987;77(11):1435-8.
1986: MA Russell; M J Jarvis; Colin Feyerabend; Y Saloojee
Reduction of tar, nicotine and carbon monoxide intake in low tar smokers.
Journal of epidemiology and community health 1986;40(1):80-5.
1984: M Jarvis; H Tunstall-Pedoe; Colin Feyerabend; C Vesey; Y Salloojee
Biochemical markers of smoke absorption and self reported exposure to passive smoking.
Journal of epidemiology and community health 1984;38(4):335-9.
1982: S R Sutton; MA Russell; R Iyer; Colin Feyerabend; Y Saloojee
Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation?
British medical journal (Clinical research ed.) 1982;285(6342):600-3.
1982: MA Russell; S R Sutton; R Iyer; Colin Feyerabend; C J Vesey
Long-term switching to low-tar low-nicotine cigarettes.
British journal of addiction 1982;77(2):145-58.
1980: MA Russell; M Jarvis; R Iyer; Colin Feyerabend
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.
British medical journal 1980;280(6219):972-6.